Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
CSPC Haihui Pharmaceutical is a major subsidiary of the CSPC Pharmaceutical Group, primarily focused on the development, manufacturing, and commercialization of finished drug products and active pharmaceutical ingredients (APIs). The company operates large-scale manufacturing facilities that comply with high-level GMP standards, producing a wide range of therapies for cardiovascular diseases, cerebrovascular conditions, and anti-infectives. Haihui plays a critical role in the group's integrated supply chain, supporting both internal product launches and external contract manufacturing services. Its portfolio includes well-established generic medications and improved formulations aimed at addressing prevalent chronic diseases in China and international markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on CSPC Haihui Pharmaceutical.